Redwood Scientific Technologies, Inc.
RSCIOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1872
P/E Ratio—
52W High$0.07
52W Low$0.0001
Redwood Scientific Technologies, Inc.（RSCI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RSCI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2020-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Gross Margin %(computed) | — | — | — | 73.63% | 57.74% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Operating Margin %(computed) | — | — | — | 3.99% | -9.94% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Net Margin %(computed) | — | — | — | 1.21% | -19.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.00 | $-0.00 | $0.55 | $-6.02 |
| Wtd Avg Shares | 0.19B | 0.18B | 0.18B | 0.17B | 0.17B |
| EBITDA | ($0.00B) | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | 3.06% | -18.18% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Redwood Scientific Technologies, Inc.
关于Redwood Scientific Technologies, Inc.（RSCI）损益表
Redwood Scientific Technologies, Inc.（RSCI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年，RSCI实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.00B)（净利率—）。
常见问题
RSCI · 4 问Redwood Scientific Technologies, Inc.（RSCI）2023财年营收为$0.00B，同比down—%。
RSCI revenueRSCI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09